ACE2 and viral infectious disease: The spike glycoprotein mediates virus entry into target cells using the Angiotensin-Converting Enzyme 2 (ACE2) receptor, and it has been shown that antibodies directed against the RBD can block viral infection of human cells in vitro and counter viral replication in vivo (30–34).